NCT07757113Not yet recruiting
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
Single site, prospective, comparative effectiveness pilot trial comparing efficacy and safety outcomes of three embolic materials (particles, liquid embolics, and Wallaby Phenox coils) in MMA embolication for cSDH.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 31 Jul 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Sanford Health
- Diseases
- Stroke
- NCT number
- NCT07757113
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Sept 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known severe allergy or contraindication to embolic materials (e.g. particles, liquids like Onyx/n-BCA, or coils)
- Inability to undergo angiography (e.g. severe renal impairment contraindicating contrast)
Other
- Ineligible for MMAE procedure, as deemed by the treating physician, for any indication (e.g. pregnancy)
- Non-chronic subdural hematoma (cSDH) indications for Middle Meningeal Artery Embolization (MMAE), including acute subdural hematoma with symptom onset \< 72 hours or mixed acute/chronic without predominant chronic features
- Pregnancy or breastfeeding
- Inability or unwillingness to complete follow-up visits at 30 and 90 days
Who the study is looking for
- Adult patients (≥ 18 years)
- Undergoing Middle Meningeal Artery Embolization (MMAE) for chronic subdural hematoma (cSDH)
- Able to provide informed consent or have a legally authorized representative (LAR) do so
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sanford USD Medical Center Coordinator of this site? Confirm its status | Sioux Falls | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.